--> Watch Danone today - stock indicated lower in pre-market -2%
Mead Johnson Nutrition sees Q2 adjusted EPS of $0.76 vs $0.89 Capital IQ Consensus Estimate; lowers FY15 adjusted EPS and rev guidance
Co announced that it is revising full-year 2015 financial guidance based on preliminary second quarter sales results.
- Preliminary second quarter constant dollar sales were 3% below the prior year quarter. Including the impact of foreign currency, preliminary reported sales were 7% below the prior year quarter.
- Strong sales of the recently launched imported products to China were insufficient to fully offset declines in the China based manufactured products. Hong Kong cross-border sales stabilized, but were below prior year levels.
- Slowing emerging market growth and dairy costs approaching five-year lows drove competitive promotional price discounting across several MJN markets in Latin America and Asia, most notably in China.
- Strong sales of the recently launched imported products to China were insufficient to fully offset declines in the China based manufactured products. Hong Kong cross-border sales stabilized, but were below prior year levels.
- Preliminary non-GAAP EPS for the second quarter of 2015 is expected to be $0.76 (vs $0.89 Capital IQ Consensus Estimate), impacted by the sales decline and increased Advertising & Promotion expenditure.
- Annual sales growth is expected to be in the range of 0% to 2% on a constant-dollar basis, previously estimated at 7%. Including the estimated impact of foreign exchange, reported sales are expected to be 2% to 4% below the prior year (calcs to ~$4.23-4.32 bln vs $4.45 Capital IQ Consensus Estimate), previously estimated to be 2% above the prior year.
- Full-year non-GAAP EPS is expected to be in the range of $3.63 to $3.78 (vs $3.94 Capital IQ Consensus Estimate), previously estimated at $3.90 to $4.00.